Tumor Heterogeneity and Tumor Immunity: A Chicken-and-Egg Problem
- PMID: 27166403
- DOI: 10.1016/j.it.2016.04.008
Tumor Heterogeneity and Tumor Immunity: A Chicken-and-Egg Problem
Abstract
The overall mutational burden of a tumor is considered to be a predictive marker for the success of checkpoint blockade therapy. A recent study by McGranahan et al. reframes this notion by showing that clonal expression of neoantigens by tumor cells, rather than overall mutational burden, determines the response to checkpoint blockade therapy.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Comment on
-
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3. Science. 2016. PMID: 26940869 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical